Clarity Pharmaceuticals (ASX: CU6) (“Clarity”), a clinical-stage radiopharmaceutical company with a mission to developnext-generation products that improve treatment outcomes for children and adults with cancer, confirms Clarity’sTargeted Copper Theranostic (TCT) products and clinical development programs using copper-67 (Cu-67 or 67Cu) areunaffected by a recent shortage of actinium-225 (Ac-225) that has led to the delay in clinical trial recruitment1-2. Clarityalso confirms that all of its Cu-67 suppliers are based in the United States, and the Company does not source any Cu-67 from Russia.
Good on CB
Suring up supply raw materials
gees i hope Novartis and Lantheus are okay ?
News: TLX Telix Pharmaceuticals Aims Up To $4.17 Bln Valuation In US IPO, page-63
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.52 |
Change
-1.330(7.06%) |
Mkt cap ! $5.862B | |||
| Open | High | Low | Value | Volume |
| $18.40 | $18.48 | $17.40 | $37.24M | 2.091M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4990 | $17.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.59 | 5897 | 1 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |